SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-19-000050
Filing Date
2019-01-14
Accepted
2019-01-14 21:50:16
Documents
2
Period of Report
2019-01-10

Document Format Files

Seq Description Document Type Size
1 form3-01142019_090101.html 3  
1 form3-01142019_090101.xml 3 1693
2 ex24-01142019_090101.htm EX-24 5746
  Complete submission text file 0001415889-19-000050.txt   8868
Mailing Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-577-3600
VistaGen Therapeutics, Inc. (Issuer) CIK: 0001411685 (see all company filings)

IRS No.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations

Mailing Address 255 N CALDWELL CIRCLE DOWNINGTOWN PA 19335
Business Address
Cunningham Ann Michelle (Reporting) CIK: 0001764572 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37761 | Film No.: 19526103